alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: 31329313@sbcglobal.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:28:31 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

John Bakalar

Fairfield, CT 06825
II

107TH CONGRESS

1ST SESSION S. 1232

To provide for the effective punishment of online child molesters, and for

other purposes.

IN THE SENATE OF THE UNITED STATES

JULY 24, 2001

Mr. MCCONNELL introduced the following bill; which was read twice and

referred to the Committee on the Judiciary

A BILL

To provide for the effective punishment of online child

molesters, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Cybermolesters En5 forcement Act of 2001’’.

6 SEC. 2. MANDATORY MINIMUM SENTENCES.

7 Section 2423 of title 18, United States Code, is

8 amended—

9 (1) in subsection (b), by inserting ‘‘not less

10 than 5 and’’ before ‘‘not more than 15’’; and
2

•S 1232 IS

1 (2) in subsection (c), by inserting ‘‘not less

2 than 5 and’’ before ‘‘not more than 15’’.

3 SEC. 3. AUTHORIZATION OF INTERCEPTION OF COMMU4 NICATIONS IN THE INVESTIGATION OF SEX5 UAL CRIMES AGAINST CHILDREN.

6 (a) CHILD PORNOGRAPHY.—Section 2516(1)(c) of

7 title 18, United States Code, is amended by inserting ‘‘sec8 tion 2252A (relating to material constituting or containing

9 child pornography),’’ after ‘‘2252 (sexual exploitation of

10 children),’’.

11 (b) TRANSPORTATION FOR ILLEGAL SEXUAL ACTIV12 ITY.—Section 2516(1) of title 18, United States Code, as

13 amended by section 3 of this Act, is amended—

14 (1) by striking ‘‘or’’ at the end of paragraph

15 (o);

16 (2) by inserting after paragraph (o) the fol17 lowing:

18 ‘‘(p) a violation of section 2422 (relating to

19 coercion and enticement) or section 2423 (relat20 ing to transportation of minors) of this title, if,

21 in connection with that violation, the sexual ac22 tivity for which a person may be charged with

23 a criminal offense would constitute a felony of24 fense under chapter 109A or 110, if that activ25 ity took place within the special maritime and
3

•S 1232 IS

1 territorial jurisdiction of the United States; or’’;

2 and

3 (3) by redesignating paragraph (p) as para4 graph (q).

5 (c) TECHNICAL AMENDMENT ELIMINATING DUPLI6 CATIVE PROVISION.—Section 2516(1) of title 18, United

7 States Code, is amended—

8 (1) by striking the first paragraph (p); and

9 (2) by inserting ‘‘or’’ at the end of paragraph

10 (o).

11 SEC. 4. CHILD PORNOGRAPHY AS CONTRABAND.

12 Section 80302(a) of title 49, United States Code, is

13 amended—

14 (1) in paragraph (5), by striking ‘‘or’’ after the

15 semicolon;

16 (2) in paragraph (6)(D), by striking the period

17 and inserting ‘‘; or’’; and

18 (3) by inserting at the end the following:

19 ‘‘(7) material involved in a violation of section

20 2252A of title 18, United States Code (relating to

21 material constituting or containing child pornog22 raphy).’’.

Æ
```

[Federal Register Volume 88, Number 174 (Monday, September 11, 2023)]
[Notices]
[Page 62420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19615]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meetings

TIME AND DATE: 2:00 p.m. on Thursday, September 14, 2023.

PLACE: The meeting will be held via remote means and/or at the 
Commission's headquarters, 100 F Street NE, Washington, DC 20549.

STATUS: This meeting will be closed to the public.

MATTERS TO BE CONSIDERED: Commissioners, Counsel to the Commissioners, 
the Secretary to the Commission, and recording secretaries will attend 
the closed meeting. Certain staff members who have an interest in the 
matters also may be present. In the event that the time, date, or 
location of this meeting changes, an announcement of the change, along 
with the new time, date, and/or place of the meeting will be posted on 
the Commission's website at https://www.sec.gov.
    The General Counsel of the Commission, or her designee, has 
certified that, in her opinion, one or more of the exemptions set forth 
in 5 U.S.C. 552b(c)(3), (5), (6), (7), (8), 9(B) and (10) and 17 CFR 
200.402(a)(3), (a)(5), (a)(6), (a)(7), (a)(8), (a)(9)(ii) and (a)(10), 
permit consideration of the scheduled matters at the closed meeting.
    The subject matter of the closed meeting will consist of the 
following topics:
    Institution and settlement of injunctive actions;
    Institution and settlement of administrative proceedings;
    Resolution of litigation claims; and
    Other matters relating to examinations and enforcement proceedings.
    At times, changes in Commission priorities require alterations in 
the scheduling of meeting agenda items that may consist of 
adjudicatory, examination, litigation, or regulatory matters.

CONTACT PERSON FOR MORE INFORMATION: For further information; please 
contact Vanessa A. Countryman from the Office of the Secretary at (202) 
551-5400.
    Authority: 5 U.S.C. 552b.

    Dated: September 7, 2023.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2023-19615 Filed 9-7-23; 11:15 am]
BILLING CODE 8011-01-P
```
Exhibit 31.1
 CERTIFICATIONS
      a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;b)
    
    Designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;c)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; andd)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
  a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
  /s/ Michael K. Farrell
Michael K. FarrellChairman of the Board, President and ChiefExecutive Officer
From: Jack Stansfield

To: E-OHPSCA2713.EBSA

Subject: Preventative Health Care

Date: Wednesday, August 10, 2011 6:09:28 PM

As a veteran teacher, a parent, and a grandparent who understands the need for and the benefits, both

medical and financial, of preventative care (An ounce of prevention is worth a pound of cure), I join

with the American Association of University Women (AAUW) in asking you to accept the

recommendations of the Institute of Medicine as pertain to coverage of preventive care under the new

health care law, and to reject any exemptions for “religious employers.” These preventive services are a

critical element of the new law and would provide countless women better access to necessary health

care.

While AAUW believes that “religious refusal” exemptions unjustly deny women access to contraceptive

services, others, driven by an ideological distaste for all contraceptive services, are pushing the

government to make exemptions even larger. Indeed, some groups are pushing for the exemption to

apply to religiously-run health providers, so hospitals with religious affiliations would be exempt from

the coverage requirement, even though they employ people of all faiths and ideologies. If granted, this

larger exemption would deny access to thousands of women just because of where they work.

I strongly urge you to ensure women have access to quality preventive care by accepting IOM’s

recommendations and rejecting the proposed religious refusal exemption provisions.
From: modesign@verizon.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 11:56:43 AM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

mary owens

Wimberley, TX 78676
Company sanitized 

Does not contain Confidential Business 

Information (CBI)

Appendix D

Draft Facility Report on Product Content
2010/15 PFOA Stewardship Program 

Draft Facility Report on Product Content

I. CHEMICAL IDENTIFICATION

Identify the product (e.g fluoropolymer dispersion) for which you are submitting information:

Product name:___Fluorinated Surfactant (oligomeric)_______

Product description (including concentrations of perfluoroalkyl chemicals 

identified in Section IV below and year of production): 

CBI

II. COMPANY IDENTIFICATION

Identify the company and location of the facility submitting information:

Company name:_AGC SEIMI CHEMICAL CO.,LTD

Site location:

 :

3-2-10,Chigasaki, Chigasaki City, Kanagawa, 253-8585 Japan

2276-2, Nada, Hirai, Kashima City, Ibaraki,314-0012 Japan

Identify a company technical contact who can respond to inquiries about the information 

submitted:

Technical contact:_Shunji Odaka

Phone:

 

Address:

_+81-467-82-4398____

3-2-10, Chigasaki, Chigasaki City, Kanagawa, 253-8585 Japan

III. PRODUCTION

Calendar year for which you are reporting: Jan 1, 2010 to Dec 31, 2010

(Normalized data based on year end run rate)

Provide the amount of the product for the reporting year at each specific site:

 Imported ___0____kgs/yr

Manufactured _CBI_kgs/yr (As active ingredients)
IV. PRODUCT CONTENT

A. CONCENTRATIONS OF RELEVANT PERFLUOROALKYL CHEMICALS

Please provide the concentrations (ppb) of various perfluoroalkyl chemicals in your product. For 

chemicals for which you do not have actual data, please provide range estimates.

CBI

B. ANALYTICAL METHODS

Analyses should be conducted using the most accurate instrumentation and procedures available 

as of the time of testing. Please provide detailed information on the methods used (including 

analytical standards used, sampling, sample treatment, analysis), assumptions made, uncertainties 

and detection limits (LOD, LOQ) for the data provided.

Active ingredients of the products and solvent/water compose commercial products.
<XBRL><?xml version="1.0" encoding="UTF-8"?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2025 Workiva--><!--r:f8136bbe-fe07-4844-8a41-47d0ecf0908d,g:029cb39c-338c-4f2b-b2be-c21a3e7f9e4b--><xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pnw="http://pinnaclewest.com/20250106" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://pinnaclewest.com/20250106">  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>  <xs:annotation>    <xs:appinfo>      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pnw-20250106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pnw-20250106_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pnw-20250106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>      <link:roleType id="DocumentEntityandInformationDEI" roleURI="http://pinnaclewest.com/role/DocumentEntityandInformationDEI">        <link:definition>0000001 - Document - Document Entity and Information DEI</link:definition>        <link:usedOn>link:presentationLink</link:usedOn>        <link:usedOn>link:calculationLink</link:usedOn>        <link:usedOn>link:definitionLink</link:usedOn>      </link:roleType>    </xs:appinfo>  </xs:annotation>  <xs:element id="pnw_ArizonaPublicServiceCompanyMember" abstract="true" name="ArizonaPublicServiceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/></xs:schema></XBRL>
Exhibit 32.1

Certification of Chief Executive Officer

I, Domenic Gatto, Chief Executive Officer of Atlantic Express Transportation Corp. (the ‘‘Company’’), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

| |     |                                                                                                                                                                                                                                                                                                 
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (i) | the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2008, as filed with the Securities and Exchange Commission (the ‘‘Report’’), fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; and

| |      |                                                                                                                                                     
| | ---- | ----------------------------------------------------------------------------------------------------------------------------------------------------
| | (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Domenic GattoDomenic Gatto
Chief Executive Officer


Date: May 14, 2008

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

---
Table of Contents

REVHOLDINGS LLC AND SUBSIDIARIES

Exhibit32.2

CERTIFICATION PURSUANT TO18 U.S.C. SECTION1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEYACT OF 2002

In connection with the Quarterly Report on Form 10-Qof REV Holdings LLC (the ‘‘Company’’) for theperiod ended June  30,  2006 as filed with the Securitiesand Exchange Commission on the date hereof (the‘‘Report’’), I, Paul G. Savas, Chief FinancialOfficer of the Company, hereby certify, pursuant to 18 U.S.C. Section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, that, to the best of my knowledge:

(1) The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

(2) The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of theCompany.

/s/ Paul G.Savas                Paul G. SavasChiefFinancial OfficerAugust 10,2006

----
LOGO

---



Exhibit 10.12



January 8, 2004



Mr. Pat Clarke

Brick Lane

Beck Hall

Tealby

Market Rasen

Lincolnshire

LN8 3XS



Re: Modifications to Terms and Conditions of Employment dated January 7, 2004



Dear Pat:



Further to our letter of offer dated January 7, 2004, I am pleased to submit the following modifications to that offer:



| | 1) |  | We have satisfactorily checked the references that you provided and hereby remove that condition from our offer. Our offer of employment is no longer conditional, with the exception
that the offer expires 5:00pm (GMT), January 9, 2004.
| | -- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2) |  | Clause 6, Period of Notice, is hereby deleted in its entirety, and replaced with the following:
| | -- |  | -----------------------------------------------------------------------------------------------



In the event of termination without cause, the Company will provide three (3) months notice to you. Should you elect
to leave the Company you will provide three (3) months notice to the Company. In the event of termination due to serious misconduct or breach of contract there will be no notice period.



Please sign below, in addition to signing the original offer letter, to indicate your
acceptance of these terms.



Signed on behalf of BakBone Software Limited:



/s/ Keith Rickard

---



Date: January 8, 2004

---



I hereby accept this
modification letter together with the original terms of the offer of employment (as modified by this letter):



Employee: /s/ Pat Clarke

---



Date: January 12, 2004

---